Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Betge, J; Kornprat, P; Pollheimer, MJ; Lindtner, RA; Schlemmer, A; Rehak, P; Vieth, M; Langner, C.
Tumor budding is an independent predictor of outcome in AJCC/UICC stage II colorectal cancer.
Ann Surg Oncol. 2012; 19(12):3706-3712
Doi: 10.1245/s10434-012-2426-z
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
- Kornprat Peter
- Langner Cord
- Co-Autor*innen der Med Uni Graz
- Pollheimer Marion
- Rehak Peter
- Schlemmer Andrea
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- In colorectal cancer, the morphology of the invasive tumor margin may reflect aggressiveness of tumor growth, thus providing important prognostic information. The tumor growth pattern according to Jass and the extent of tumor budding were analyzed in patients with American Joint Committee on Cancer/Union for International Cancer Control (AJCC/UICC) stage II disease. Tumors of 120 randomly selected patients with AJCC/UICC stage II disease were retrospectively reviewed for tumor growth pattern (expanding vs. infiltrating) and the extent of tumor budding, with high-grade budding reflecting presence of 10 or more budding foci scattered at the invasive tumor margin. Progression-free and cancer-specific survivals were determined by the Kaplan-Meier method. For multivariable analysis, Cox's proportional hazards regression models were performed. The infiltrating growth pattern was significantly associated with histological subtype and lymphovascular invasion, while high-grade budding was significantly associated with tumor grade and lymphovascular invasion. High-grade budding, but not the infiltrating growth pattern, was significantly associated with outcome in univariable analysis. Cox's proportional hazards regression models proved tumor budding to be an independent predictor of disease progression (hazard ratio 3.91, 95 % confidence interval 1.3-11.77; P = 0.02) and cancer-related death (hazard ratio 5.90, 95 % confidence interval 1.62-21.51; P = 0.007). The combination of infiltrating growth pattern and high-grade budding did not have a stronger prognostic significance than tumor budding alone. Tumor budding independently predicted patient outcome in patients with AJCC/UICC stage II colorectal cancer and may therefore be used for accurate prognostication, patient counseling, and design of clinical trials by using integrated multimodal therapy.
- Find related publications in this database (using NLM MeSH Indexing)
- Adenocarcinoma - mortality Adenocarcinoma - secondary Adenocarcinoma - surgery
- Adenocarcinoma, Mucinous - mortality Adenocarcinoma, Mucinous - secondary Adenocarcinoma, Mucinous - surgery
- Adult -
- Aged -
- Aged, 80 and over -
- Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Colorectal Neoplasms - surgery
- Disease Progression -
- Female -
- Follow-Up Studies -
- Humans -
- Male -
- Middle Aged -
- Neoplasm Grading -
- Neoplasm Invasiveness -
- Neoplasm Recurrence, Local - mortality Neoplasm Recurrence, Local - pathology Neoplasm Recurrence, Local - surgery
- Neoplasm Staging -
- Prognosis -
- Retrospective Studies -
- Risk Factors -
- Survival Rate -